Skip to main content
Erschienen in: Abdominal Radiology 12/2016

22.09.2016

Diffusion MRI of uterine and ovarian masses: identifying the benign lesions

verfasst von: Amir H. Davarpanah, Avinash Kambadakone, Nagaraj S. Holalkere, Alexander R. Guimaraes, Peter F. Hahn, Susanna I. Lee

Erschienen in: Abdominal Radiology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study was to assess the diagnostic performance of qualitative and quantitative diffusion-weighted imaging (DWI) in differentiating benign from malignant ovarian and uterine masses.

Materials and methods

Institutional review board approval was obtained for this HIPAA-compliant retrospective study, with waiver of informed consent. DWI MRIs of 222 women acquired over 1.5 years were evaluated. Reference standard was pathology or follow-up imaging. For qualitative assessment, two radiologists independently reviewed DWI and apparent diffusion coefficient (ADC) images for diffusion restriction. Differences were resolved by consensus. For quantitative assessment, a single reader measured ADC values. Readers were blinded to the reference standard.

Results

222 lesions, 121 ovarian (99 benign and 22 malignant) and 101 uterine (54 benign and 47 malignant), were included. Final diagnosis was established with pathology in 129 (58%) or with imaging follow-up in 93 (42%). Mean (range) follow-up interval was 27 (13–48) months. Qualitative assessment yielded sensitivity (ratio, 95% CI), specificity, PPV and NPV of 100% (22/22, 85–100), 68% (68/99, 58–76), 41% (22/54, 27–54), and 100% (68/68, 94–100) for ovarian and 94% (44/47, 83–98), 91% (49/54, 80–96), 90% (44/49, 78–95) and 94% (49/52, 84–98) for uterine malignancies. ADC (mean ± SD) between benign ovarian [(1.11 ± 0.76) × 10−3 mm2/s] vs. malignant [(0.71 ± 0.26) × 10−3 mm2/s] lesions was significantly different (p < 0.001). ADC cutoff value of 1.55 × 10−3 mm2/s for ovarian lesions resulted in 99.9% confidence for the absence of malignancy. ADC (mean ± SD) of benign uterine [(0.64 ± 0.38) × 10−3 mm2/s] vs. malignant [(0.68 ± 0.19) × 10−3 mm2/s] lesions was not significantly different (P < 0.54).

Conclusion

Quantitative and qualitative DWI assessment can be used to confidently characterize a subset of ovarian lesions as benign. With uterine lesions, although DWI is useful in differentiating benign from malignant lesions, the technique does not allow for definitive quantitative characterization.
Literatur
1.
Zurück zum Zitat Kinkel K, Lu Y, Mehdizade A, Pelte MF, Hricak H (2005) Indeterminate ovarian mass at US: incremental value of second imaging test for characterization—meta-analysis and Bayesian analysis. Radiology 236(1):85–94CrossRefPubMed Kinkel K, Lu Y, Mehdizade A, Pelte MF, Hricak H (2005) Indeterminate ovarian mass at US: incremental value of second imaging test for characterization—meta-analysis and Bayesian analysis. Radiology 236(1):85–94CrossRefPubMed
2.
Zurück zum Zitat Anthoulakis C, Nikoloudis N (2014) Pelvic MRI as the “gold standard” in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review. Gynecol Oncol 132(3):661–668CrossRefPubMed Anthoulakis C, Nikoloudis N (2014) Pelvic MRI as the “gold standard” in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review. Gynecol Oncol 132(3):661–668CrossRefPubMed
3.
Zurück zum Zitat Iyer VR, Lee SI (2010) MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization. AJR Am J Roentgenol 194(2):311–321CrossRefPubMed Iyer VR, Lee SI (2010) MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization. AJR Am J Roentgenol 194(2):311–321CrossRefPubMed
4.
Zurück zum Zitat Cornfeld D, Israel G, Martel M, et al. (2010) MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol 74(1):241–249CrossRefPubMed Cornfeld D, Israel G, Martel M, et al. (2010) MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol 74(1):241–249CrossRefPubMed
5.
Zurück zum Zitat Goto A, Takeuchi S, Sugimura K, Maruo T (2002) Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 12(4):354–361CrossRefPubMed Goto A, Takeuchi S, Sugimura K, Maruo T (2002) Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 12(4):354–361CrossRefPubMed
6.
Zurück zum Zitat Harry VN (2010) Novel imaging techniques as response biomarkers in cervical cancer. Gynecol Oncol 116(2):253–261CrossRefPubMed Harry VN (2010) Novel imaging techniques as response biomarkers in cervical cancer. Gynecol Oncol 116(2):253–261CrossRefPubMed
7.
Zurück zum Zitat Kilickesmez O, Cimilli T, Inci E, et al. (2009) Diffusion-weighted MRI of urinary bladder and prostate cancers. Diagn Interv Radiol 15(2):104–110PubMed Kilickesmez O, Cimilli T, Inci E, et al. (2009) Diffusion-weighted MRI of urinary bladder and prostate cancers. Diagn Interv Radiol 15(2):104–110PubMed
8.
Zurück zum Zitat Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188(6):1622–1635CrossRefPubMed Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188(6):1622–1635CrossRefPubMed
9.
Zurück zum Zitat McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA (2008) Diffusion-weighted MRI in cervical cancer. Eur Radiol 18(5):1058–1064CrossRefPubMed McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA (2008) Diffusion-weighted MRI in cervical cancer. Eur Radiol 18(5):1058–1064CrossRefPubMed
10.
Zurück zum Zitat Beddy P, Moyle P, Kataoka M, et al. (2012) Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 262(2):530–537CrossRefPubMed Beddy P, Moyle P, Kataoka M, et al. (2012) Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 262(2):530–537CrossRefPubMed
11.
Zurück zum Zitat Donati OF, Chong D, Nanz D, et al. (2014) Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiology 270(2):454–463CrossRefPubMed Donati OF, Chong D, Nanz D, et al. (2014) Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiology 270(2):454–463CrossRefPubMed
12.
Zurück zum Zitat Kim S, Jain M, Harris AB, et al. (2009) T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology 251(3):796–807CrossRefPubMed Kim S, Jain M, Harris AB, et al. (2009) T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology 251(3):796–807CrossRefPubMed
13.
Zurück zum Zitat Namimoto T, Awai K, Nakaura T, et al. (2009) Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 19(3):745–760CrossRefPubMed Namimoto T, Awai K, Nakaura T, et al. (2009) Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 19(3):745–760CrossRefPubMed
14.
Zurück zum Zitat Fujii S, Kakite S, Nishihara K, et al. (2008) Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging 28(5):1149–1156CrossRefPubMed Fujii S, Kakite S, Nishihara K, et al. (2008) Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging 28(5):1149–1156CrossRefPubMed
15.
Zurück zum Zitat Thomassin-Naggara I, Darai E, Cuenod CA, et al. (2009) Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol 19(6):1544–1552CrossRefPubMed Thomassin-Naggara I, Darai E, Cuenod CA, et al. (2009) Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol 19(6):1544–1552CrossRefPubMed
16.
Zurück zum Zitat Li W, Chu C, Cui Y, Zhang P, Zhu M (2012) Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components. Abdom Imaging 37(5):897–903CrossRefPubMed Li W, Chu C, Cui Y, Zhang P, Zhu M (2012) Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components. Abdom Imaging 37(5):897–903CrossRefPubMed
17.
Zurück zum Zitat Tamai K, Koyama T, Saga T, et al. (2008) The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 18(4):723–730CrossRefPubMed Tamai K, Koyama T, Saga T, et al. (2008) The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 18(4):723–730CrossRefPubMed
18.
Zurück zum Zitat Landis JR, Koch GG (1977) An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33(2):363–374CrossRefPubMed Landis JR, Koch GG (1977) An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33(2):363–374CrossRefPubMed
19.
Zurück zum Zitat Song JS, Hwang SB, Chung GH, Jin GY (2016) Intra-individual, inter-vendor comparison of diffusion-weighted mr imaging of upper abdominal organs at 3.0 Tesla with an emphasis on the value of normalization with the spleen. Korean J Radiol 17(2):209–217CrossRefPubMedPubMedCentral Song JS, Hwang SB, Chung GH, Jin GY (2016) Intra-individual, inter-vendor comparison of diffusion-weighted mr imaging of upper abdominal organs at 3.0 Tesla with an emphasis on the value of normalization with the spleen. Korean J Radiol 17(2):209–217CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Inada Y, Matsuki M, Nakai G, et al. (2009) Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging? Eur J Radiol 70(1):122–127CrossRefPubMed Inada Y, Matsuki M, Nakai G, et al. (2009) Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging? Eur J Radiol 70(1):122–127CrossRefPubMed
21.
Zurück zum Zitat Naganawa S, Sato C, Kumada H, et al. (2005) Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15(1):71–78CrossRefPubMed Naganawa S, Sato C, Kumada H, et al. (2005) Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15(1):71–78CrossRefPubMed
22.
Zurück zum Zitat Tamai K, Koyama T, Saga T, et al. (2007) Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 26(3):682–687CrossRefPubMed Tamai K, Koyama T, Saga T, et al. (2007) Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 26(3):682–687CrossRefPubMed
23.
Zurück zum Zitat Weinreb JC, Barentsz JO, Choyke PL, et al. (2016) PI-RADS Prostate Imaging-Reporting and Data System: 2015, Version 2. Eur Urol 69(1):16–40CrossRefPubMed Weinreb JC, Barentsz JO, Choyke PL, et al. (2016) PI-RADS Prostate Imaging-Reporting and Data System: 2015, Version 2. Eur Urol 69(1):16–40CrossRefPubMed
24.
Zurück zum Zitat Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61(3):1056–1065CrossRefPubMed Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61(3):1056–1065CrossRefPubMed
25.
Zurück zum Zitat Thomassin-Naggara I, Aubert E, Rockall A, et al. (2013) Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology 267(2):432–443CrossRefPubMed Thomassin-Naggara I, Aubert E, Rockall A, et al. (2013) Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology 267(2):432–443CrossRefPubMed
Metadaten
Titel
Diffusion MRI of uterine and ovarian masses: identifying the benign lesions
verfasst von
Amir H. Davarpanah
Avinash Kambadakone
Nagaraj S. Holalkere
Alexander R. Guimaraes
Peter F. Hahn
Susanna I. Lee
Publikationsdatum
22.09.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 12/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0909-2

Weitere Artikel der Ausgabe 12/2016

Abdominal Radiology 12/2016 Zur Ausgabe

Classics in Abdominal Imaging

The T2 shading sign

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.